328
Views
3
CrossRef citations to date
0
Altmetric
Liquid Chromatography

Simultaneous Determination of Free Cortisol, Cortisone and their Tetrahydrometabolites in Urine by Single Solvent Extraction and Liquid Chromatography–Tandem Mass Spectrometry

, , , , , , & show all
Pages 2764-2781 | Received 12 Feb 2019, Accepted 29 Mar 2019, Published online: 10 Apr 2019

References

  • Andrews, R. C., O. Herlihy, D. E. Livingstone, R. Andrew, and B. R. Walker. 2002. Abnormal cortisol metabolism and tissue sensitivity to cortisol in patients with glucose intolerance. Journal of Clinical Endocrinology and Metabolism 87 (12):5587–93. doi:10.1210/jc.2002-020048.
  • Andrews, R. C., and B. R. Walker. 1999. Glucocorticoids and insulin resistance: old hormones, new targets. Clinical Science 96 (5):513–23.
  • Bahr, N. I., R. Palme, U. Mohle, J. K. Hodges, and M. Heistermann. 2000. Comparative aspects of the metabolism and excretion of cortisol in three individual nonhuman primates. General and Comparative Endocrinology 117 (3):427–38. doi:10.1006/gcen.1999.7431.
  • Baranov, P. A., S. A. Appolonova, and G. M. Rodchenkov. 2010. The potential use of complex derivatization procedures in comprehensive HPLC-MS/MS detection of anabolic steroids. Drug Testing and Analysis 2 (10):475–88. doi:10.1002/dta.163.
  • Carvalho, V. M. 2012. The coming of age of liquid chromatography coupled to tandem mass spectrometry in the endocrinology laboratory. Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences 883–884:50–8. doi:10.1016/j.jchromb.2011.08.027.
  • Casals, G., J. Marcos, O. J. Pozo, P. Aguilera, C. Herrero, and J. To-Figueras. 2013. Gas chromatography-mass spectrometry profiling of steroids in urine of patients with acute intermittent porphyria. Clinical Biochemistry 46 (9):819–24. doi:10.1016/j.clinbiochem.2013.03.001.
  • Cho, H. J., J. D. Kim, W. Y. Lee, B. C. Chung, and M. H. Choi. 2009. Quantitative metabolic profiling of 21 endogenous corticosteroids in urine by liquid chromatography-triple quadrupole-mass spectrometry. Analytica Chimica Acta 632 (1):101–8. doi:10.1016/j.aca.2008.10.059.
  • Cho, Y. D., and M. H. Choi. 2006. Alternative sample preparation techniques in gas chromatographic-mass spectrometric analysis of urinary androgenic steroids. Bulletin of the Korean Chemical Society 27 (9):1315–22.
  • Choi, M. H., J. R. Hahm, B. H. Jung, and B. C. Chung. 2002. Measurement of corticoids in the patients with clinical features indicative of mineralocorticoid excess. Clinica Chimica Acta 320 (1–2):95–9. doi:10.1016/S0009-8981(02)00050-5.
  • Cooper, M. S., A. Blumsohn, P. E. Goddard, W. A. Bartlett, C. H. Shackleton, R. Eastell, M. Hewison, and P. M. Stewart. 2003. 11beta-hydroxysteroid dehydrogenase type 1 activity predicts the effects of glucocorticoids on bone. Journal of Clinical Endocrinology and Metabolism 88 (8):3874–7. doi:10.1210/jc.2003-022025.
  • Cuzzola, A., F. Mazzini, and A. Petri. 2014. A comprehensive study for the validation of a LC-MS/MS method for the determination of free and total forms of urinary cortisol and its metabolites. Journal of Pharmaceutical and Biomedical Analysis 94:203–9. doi:10.1016/j.jpba.2014.02.003.
  • Cuzzola, A., A. Petri, F. Mazzini, and P. Salvadori. 2009. Application of hyphenated mass spectrometry techniques for the analysis of urinary free glucocorticoids. Rapid Communications in Mass Spectrometry 23 (18):2975–82. doi:10.1002/rcm.4214.
  • Edwards, C. R. W., B. R. Walker, R. Benediktsson, and J. R. Seckl. 1993. Congenital and acquired syndromes of apparent mineralocorticoid excess. Journal of Steroid Biochemistry and Molecular Biology 45 (1–3):1–5. doi:10.1016/0960-0760(93)90114-C.
  • European Medicines Agency. 2011. Guideline on bioanalytical method validation. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2011/08/WC500109686.pdf. Accessed 27 March 2019
  • Furuta, T., N. Eguchi, H. Shibasaki, and Y. Kasuya. 2000. Simultaneous determination of endogenous and 13C-labelled cortisols and cortisones in human plasma by stable isotope dilution mass spectrometry. Journal of Chromatography B 738 (1):119–27. doi:10.1016/S0378-4347(99)00496-X.
  • Hammer, F., and P. M. Stewart. 2006. Cortisol metabolism in hypertension. Best Practice & Research. Clinical Endocrinology & Metabolism 20 (3):337–53. doi:10.1016/j.beem.2006.07.001.
  • Hauser, B., T. Deschner, and C. Boesch. 2008. Development of a liquid chromatography-tandem mass spectrometry method for the determination of 23 endogenous steroids in small quantities of primate urine. Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences 862 (1–2):100–12. doi:10.1016/j.jchromb.2007.11.009.
  • Hoshiro, M., Y. Ohno, H. Masaki, H. Iwase, and N. Aoki. 2006. Comprehensive study of urinary cortisol metabolites in hyperthyroid and hypothyroid patients. Clinical Endocrinology 64 (1):37–45. doi:10.1111/j.1365-2265.2005.02412.x.
  • Ikegawa, S., M. Hasegawa, R. Okihara, C. Shimidzu, H. Chiba, T. Iida, and K. Mitamura. 2009. Simultaneous determination of twelve tetrahydrocorticosteroid glucuronides in human urine by liquid chromatography/electrospray ionization-linear ion trap mass spectrometry. Analytical Chemistry 81 (24):10124–35. doi:10.1021/ac9018632.
  • Kasuya, Y., H. Shibasaki, and T. Furuta. 2000. The use of deuterium-labeled cortisol for in vivo evaluation of renal 11b-HSD activity in man: urinary excretion of cortisol, cortisone and their A-ring reduced metabolites. Steroids 65 (2):89–97. doi:10.1016/S0039-128X(99)00086-0.
  • Kosicka, K.,. A. Siemiątkowska, D. Pałka, A. Szpera-Goździewicz, G. H. Bręborowicz, and F. K. Główka. 2017. Detailed analysis of cortisol, cortisone and their tetrahydro- and allo-tetrahydrometabolites in human urine by LC–MS/MS. Journal of Pharmaceutical and Biomedical Analysis 140:174–81. doi:10.1016/j.jpba.2017.03.039.
  • Magnisali, P., M. B. Chalioti, T. Livadara, M. Mataragas, S. Paliatsiou, A. Malamitsi-Puchner, and P. Moutsatsou. 2011. Simultaneous quantification of 17alpha-OH progesterone, 11-deoxycortisol, Delta4-androstenedione, cortisol and cortisone in newborn blood spots using liquid chromatography-tandem mass spectrometry. Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences 879 (19):1565–72. doi:10.1016/j.jchromb.2011.03.048.
  • Magnisali, P., M. Dracopoulou, M. Mataragas, A. Dacou-Voutetakis, and P. Moutsatsou. 2008. Routine method for the simultaneous quantification of 17alpha-hydroxyprogesterone, testosterone, dehydroepiandrosterone, androstenedione, cortisol, and pregnenolone in human serum of neonates using gas chromatography-mass spectrometry. Journal of Chromatography A 1206 (2):166–77. doi:10.1016/j.chroma.2008.07.057.
  • Morfin, R. 2002. Involvement of steroids and cytochromes P(450) species in the triggering of immune defenses. The Journal of Steroid Biochemistry and Molecular Biology 80 (3):273–90.
  • Mussig, K., T. Remer, A. Fritsche, H. U. Haring, and C. Maser-Gluth. 2009. Urinary free cortisone, but not cortisol, is associated with urine volume in severe obesity. Steroids 74 (9):742–5. doi:10.1016/j.steroids.2009.03.007.
  • Nozaki, O. 2001. Steroid analysis for medical diagnosis. Journal of Chromatography. A 935 (1–2):267–78.
  • Palermo, M., C. H. Shackleton, F. Mantero, and P. M. Stewart. 1996. Urinary free cortisone and the assessment of 11 beta-hydroxysteroid dehydrogenase activity in man. Clinical Endocrinology 45 (5):605–11. doi:10.1046/j.1365-2265.1996.00853.x.
  • Pavlovic, R., F. T. Cannizzo, S. Panseri, B. Biolatti, N. Trutic, P. A. Biondi, and L. Chiesa. 2013. Tetrahydro-metabolites of cortisol and cortisone in bovine urine evaluated by HPLC-ESI-mass spectrometry. Journal of Steroid Biochemistry and Molecular Biology 135:30–5. doi:10.1016/j.jsbmb.2012.12.015.
  • Phillips, D. I. W., D. J. P. Barker, C. H. D. Fall, J. R. Seckl, C. B. Whorwood, P. J. Wood, and B. R. Walker. 1998. Elevated plasma cortisol concentrations: a link between low birth weight and the insulin resistance syndrome? Journal of Clinical Endocrinology and Metabolism 83 (3):757–60. doi:10.1210/jcem.83.3.4634.
  • Pujos, E., M. M. Flament-Waton, O. Paisse, and M. F. Grenier-Loustalot. 2005. Comparison of the analysis of corticosteroids using different techniques. Analytical and Bioanalytical Chemistry 381 (1):244–54. doi:10.1007/s00216-004-2890-9.
  • Raffaelli, A., A. Saba, E. Vignali, C. Marcocci, and P. Salvadori. 2006. Direct determination of the ratio of tetrahydrocortisol + allo-tetrahydrocortisol to tetrahydrocortisone in urine by LC-MS-MS. Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences 830 (2):278–85. doi:10.1016/j.jchromb.2005.11.011.
  • Rauh, M. 2010. Steroid measurement with LC-MS/MS. Application examples in pediatrics. Journal of Steroid Biochemistry and Molecular Biology 121 (3–5):520–7. doi:10.1016/j.jsbmb.2009.12.007.
  • Remer, T., C. Maser-Gluth, and S. A. Wudy. 2008. Glucocorticoid Measurements in Health and Disease – Metabolic Implications and the Potential of 24-h Urine Analyses. Mini-Reviews in Medicinal Chemistry 8 (2):153–70. doi:10.2174/138955708783498096.
  • Saba, A., A. Raffaelli, A. Cupisti, A. Petri, C. Marcocci, and P. Salvadori. 2009. Recent advances in the assessment of the ratios of cortisol to cortisone and of some of their metabolites in urine by LC-MS-MS. Journal of Mass Spectrometry 44 (4):541–8. doi:10.1002/jms.1530.
  • Stewart, P. M. 1996. 11β-Hydroxysteroid dehydrogenase: implications for clinical medicine. Clinical Endocrinology 44 (5):493–9. doi:10.1046/j.1365-2265.1996.716535.x.
  • Taylor, R. L., D. Machacek, and R. J. Singh. 2002. Validation of a High-Throughput Liquid Chromatography–Tandem Mass Spectrometry Method for Urinary Cortisol and Cortisone. Clinical Chemistry 48 (9):1511–9.
  • Tello, F. L., and D. M. Hernández. 2000. Performance evaluation of nine hormone assays on the Immulite 2000® immunoassay system. Clinical Chemistry and Laboratory Medicine 38 (10):1039–42.
  • Tiosano, D., I. Eisentein, D. Militianu, G. P. Chrousos, and Z. Hochberg. 2003. 11beta-hydroxysteroid dehydrogenase activity in hypothalamic obesity. Journal of Clinical Endocrinology and Metabolism 88 (1):379–84. doi:10.1210/jc.2002-020511.
  • Tomlinson, J. W., E. A. Walker, I. J. Bujalska, N. Draper, G. G. Lavery, M. S. Cooper, M. Hewison, and P. M. Stewart. 2004. 11beta-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response. Endocrine Reviews 25 (5):831–66. doi:10.1210/er.2003-0031.
  • Trufelli, H., P. Palma, G. Famiglini, and A. Cappiello. 2011. An overview of matrix effects in liquid chromatography-mass spectrometry. Mass Spectrometry Reviews 30 (3):491–509. doi:10.1002/mas.20298.
  • Tsilchorozidou, T.,. J. W. Honour, and G. S. Conway. 2003. Altered cortisol metabolism in polycystic ovary syndrome: insulin enhances 5alpha-reduction but not the elevated adrenal steroid production rates. Journal of Clinical Endocrinology and Metabolism 88 (12):5907–13. doi:10.1210/jc.2003-030240.
  • Turpeinen, U., H. Markkanen, T. Sane, and E. Hamalainen. 2006. Determination of free tetrahydrocortisol and tetrahydrocortisone ratio in urine by liquid chromatography-tandem mass spectrometry. Scandinavian Journal of Clinical and Laboratory Investigation 66 (2):147–59. doi:10.1080/00365510500474504.
  • Weltring, A., F. S. Schaebs, S. E. Perry, and T. Deschner. 2012. Simultaneous measurement of endogenous steroid hormones and their metabolites with LC-MS/MS in faeces of a New World primate species, Cebus capucinus. Physiology & Behavior 105 (2):510–21. doi:10.1016/j.physbeh.2011.09.004.
  • Yamashita, K., R. Nakagawa, M. Okuyama, S. Honma, M. Takahashi, and M. Numazawa. 2008. Simultaneous determination of tetrahydrocortisol, allotetrahydrocortisol and tetrahydrocortisone in human urine by liquid chromatography-electrospray ionization tandem mass spectrometry. Steroids 73 (7):727–37. doi:10.1016/j.steroids.2008.02.009.
  • Zhai, X., F. Chen, C. Zhu, and Y. Lu. 2015. A simple LC-MS/MS method for the determination of cortisol, cortisone and tetrahydro-metabolites in human urine: assay development, validation and application in depression patients. Journal of Pharmaceutical and Biomedical Analysis 107:450–5. doi:10.1016/j.jpba.2015.01.041.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.